A Glance at Some of the Challenges of the GC Role in Pharma

Galit Gonen, Senior Vice President & General Counsel for Teva Europe, Teva Pharmaceuticals, UK

In the heavily regulated environment in which pharmaceutical companies operate, success is defined by ensuring corporate compliance with disparate laws and regulations without fettering the creativity and innovation on which pharmaceutical companies depend. Business success can deliver life changing outcomes to patients worldwide. It is fundamental that the GC in a pharmaceutical company understands and facilitates this goal. Diminished drug pipelines have required companies to rethink the drug discovery process and move away from the search for new, small molecule drugs to focus instead on the re-purposing of known drugs and development of biologics and "personalised" medicines. New business models, often involving collaboration with third parties including competitors, universities and charities have been introduced. There is increased use of computer aided drug design, big data and artificial intelligence (“e-health”). All give rise to numerous legal issues: how will outputs from collaborative research be owned, protected and commercialised; what patient data can be used and how, in the drug discovery process for the benefit of society; how will regulators approve bespoke drugs for small patient populations for which a standard clinical trial is not feasible; how will pricing and reimbursement by governments and healthcare providers be determined given the pressures on healthcare budgets?

Read full paper Subscribe to the IICJ
United Kingdom Management Pharmaceutical September 2016 Vol. 9, No. 36, Summer 2016

Galit Gonen

More

Dr Galit Gonen is the General Counsel for Teva Europe in an expanded role which also includes the European IP litigations. Dr Gonen began her career as a pharmacist. After passing the Israel Bar Association exam, she worked as an associate for a privat

Teva Pharmaceuticals

More

Headquartered in Israel, Teva is the world’s largest generics company, with a sizeable innovation speciality business. Teva Europe HQ is in Amsterdam and active across 36 countries. Teva Europe's 15,000 employees touch the lives of billions of people -

United Kingdom Management Pharmaceutical September 2016 Vol. 9, No. 36, Summer 2016